BDBM50162825 1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxy-propyl}-piperidin-4-yl)-3-isopropyl-1,3-dihydro-benzoimidazol-2-one::CHEMBL181564

SMILES CC(C)n1c2ccccc2n(C2CCN(CC(O)Cn3nc(c4CN(CCc34)C(C)=O)-c3ccc(Cl)c(C)c3)CC2)c1=O

InChI Key InChIKey=CBSIMORNOMWZGW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50162825   

TargetCathepsin S(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50162825(1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5...)
Affinity DataIC50:  100nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed